help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warfel, J. M.
Right arrow Articles by D’Agnillo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warfel, J. M.
Right arrow Articles by D’Agnillo, F.
(American Journal of Pathology. 2005;166:1871-1881.)
© 2005 American Society for Investigative Pathology

Anthrax Lethal Toxin Induces Endothelial Barrier Dysfunction

Jason M. Warfel, Amber D. Steele and Felice D’Agnillo

From the Laboratory of Biochemistry and Vascular Biology, Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland

Hemorrhage and pleural effusion are prominent pathological features of systemic anthrax infection. We examined the effect of anthrax lethal toxin (LT), a major virulence factor of Bacillus anthracis, on the barrier function of primary human lung microvascular endothelial cells. We also examined the distribution patterns of cytoskeletal actin and vascular endothelial-cadherin (VE-cadherin), both of which are involved in barrier function regulation. Endothelial monolayers cultured on porous membrane inserts were treated with the LT components lethal factor (LF) and protective antigen (PA) individually, or in combination. LT induced a concentration- and time-dependent decrease in transendothelial electrical resistance that correlated with increased permeability to fluorescently labeled albumin. LT also produced a marked increase in central actin stress fibers and significantly altered VE-cadherin distribution as revealed by immunofluorescence microscopy and cell surface enzyme-linked immunosorbent assay. Treatment with LF, PA, or the combination of an inactive LF mutant and PA did not alter barrier function or the distribution of actin or VE-cadherin. LT-induced barrier dysfunction was not dependent on endothelial apoptosis or necrosis. The present findings support a possible role for LT-induced barrier dysfunction in the vascular permeability changes accompanying systemic anthrax infection.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. M. Warfel and F. D'Agnillo
Anthrax Lethal Toxin Enhances TNF-Induced Endothelial VCAM-1 Expression via an IFN Regulatory Factor-1-Dependent Mechanism
J. Immunol., June 1, 2008; 180(11): 7516 - 7524.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-C. Chung, T. G. Popova, S. C. Jorgensen, L. Dong, V. Chandhoke, C. L. Bailey, and S. G. Popov
Degradation of Circulating von Willebrand Factor and Its Regulator ADAMTS13 Implicates Secreted Bacillus anthracis Metalloproteases in Anthrax Consumptive Coagulopathy
J. Biol. Chem., April 11, 2008; 283(15): 9531 - 9542.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Xu, H. Fang, and D. M. Frucht
Anthrax Lethal Toxin Increases Superoxide Production in Murine Neutrophils via Differential Effects on MAPK Signaling Pathways
J. Immunol., March 15, 2008; 180(6): 4139 - 4147.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. E. Bolcome III, S. E. Sullivan, R. Zeller, A. P. Barker, R. J. Collier, and J. Chan
Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature
PNAS, February 19, 2008; 105(7): 2439 - 2444.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Rossi, A. V. Velentza, D. M. Steinhorn, D. M. Watterson, and M. S. Wainwright
MLCK210 gene knockout or kinase inhibition preserves lung function following endotoxin-induced lung injury in mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1327 - L1334.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Sherer, Y. Li, X. Cui, and P. Q. Eichacker
Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 211 - 221.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-C. Chung, T. G. Popova, B. A. Millis, D. V. Mukherjee, W. Zhou, L. A. Liotta, E. F. Petricoin, V. Chandhoke, C. Bailey, and S. G. Popov
Secreted Neutral Metalloproteases of Bacillus anthracis as Candidate Pathogenic Factors
J. Biol. Chem., October 20, 2006; 281(42): 31408 - 31418.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Fang, L. Xu, T. Y. Chen, J. M. Cyr, and D. M. Frucht
Anthrax Lethal Toxin Has Direct and Potent Inhibitory Effects on B Cell Proliferation and Immunoglobulin Production
J. Immunol., May 15, 2006; 176(10): 6155 - 6161.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
P. Keim, M. Mock, J. Young, and T. M. Koehler
The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05".
J. Bacteriol., May 1, 2006; 188(10): 3433 - 3441.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. C. Culley, D. M. Pinson, A. Chakrabarty, M. S. Mayo, and S. M. LeVine
Pathophysiological Manifestations in Mice Exposed to Anthrax Lethal Toxin
Infect. Immun., October 1, 2005; 73(10): 7006 - 7010.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.